Recombinant PCSK9 (Lodelcizumab Biosimilar) antibody

Catalog No. ABIN7675990

This anti-PCSK9 (Lodelcizumab Biosimilar) antibody is a Human Monoclonal antibody detecting PCSK9 (Lodelcizumab Biosimilar) in ELISA, BLI, FACS, Func and SPR. Suitable for Human.

Quick Overview for Recombinant PCSK9 (Lodelcizumab Biosimilar) antibody (ABIN7675990)

Target: PCSK9 (Lodelcizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PCSK9 (Lodelcizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-PCSK9 (Lodelcizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-PCSK9 Reference Antibody (lodelcizumab)

Characteristics: Anti-PCSK9 Reference Antibody (lodelcizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for PCSK9 (Lodelcizumab Biosimilar)

Target: PCSK9 (Lodelcizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q8NBP7